New grants support organoids, organs-on-chips, and in silico approaches to reduce reliance on animal models, but experts say ...
NDTV Profit on MSN
Who is Vas Narasimhan? Novartis CEO appointed to Anthropic's board
Novartis CEO Vas Narasimhan has joined Anthropic's board of directors, marking the first time a healthcare executive has ...
A new agentic AI application aims to speed up drug development, helping bring new medical treatments to patients faster.
Brains Bioceutical Corp. (“Brains Bio”), a global life sciences company advancing a clinically validated portfolio of therapeutic and pharmaceutical programs, today announced the appointment of Dr.
Spiral Therapeutics, Inc. ("Spiral Therapeutics" or "Spiral"), a clinical-stage company developing novel therapies for inner ear disorders, today announced the closing of its $27 million Series B ...
Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Kent Lupino as chief marketing officer. Lupino ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results